Log in
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Stage
Employees
Links
Niels C. Riedemann
4 members
3 members
2 members
Tubulis
1 follower
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Verve Therapeutics
53 followers
Discover companies